Serotonin receptors, novel targets of sulforaphane identified by proteomic analysis in Caco-2 cells

Cancer Research

Volumn 68, Issue 13, 2008, Pages 5487-5491

  Mastrangelo, Lina ^a   Cassidy, Aedin ^a   Mulholland, Francis ^b   Wang, Wei ^a   Bao, Yongping ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; NICOTINIC RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SULFORAPHANE; UNCLASSIFIED DRUG; PHARMACOLOGICAL BIOMARKER; PROTEOME; SEROTONIN ANTAGONIST; SULFORAFAN; THIOCYANIC ACID DERIVATIVE; TUMOR MARKER;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL; CANCER GROWTH; CELL STRAIN CACO 2; COLON ADENOCARCINOMA; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; MASS SPECTROMETER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; PROTEOMICS; RECEPTOR DOWN REGULATION; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; ADENOCARCINOMA; COLON TUMOR; DRUG DELIVERY SYSTEM; DRUG SCREENING; ISOLATION AND PURIFICATION; METABOLISM;

ADENOCARCINOMA; BIOMARKERS, PHARMACOLOGICAL; CACO-2 CELLS; COLONIC NEOPLASMS; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; PROTEOME; PROTEOMICS; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; THIOCYANATES; TUMOR MARKERS, BIOLOGICAL;

EID: 48549088789     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-6171     Document Type: Article

References (30)

1. Zhang Y, Talalay P, Cho CG, Posner GH. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 1992;89:2399-403.
2. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002; 62:5196-203.
3. Basten GP, Bao YP, Williamson G. Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells. Carcinogenesis 2002;23:1399-404.
4. Kelloff GJ, Crowell JA, Steele VE, et al. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 2000;130:467-71S.
5. Bacon JR, Williamson G, Garner RC, Lappin G, Langouët S, Bao Y. Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes. Carcinogenesis 2003;24:1903-11.
6. Jakubíková J, Sedlák J, Bacon J, Goldson A, Bao Y. Effects of MEK1 and PI3K inhibitors on allyl-, benzyl- and phenylethyl- isothiocyanate-induced G2/M arrest and cell death in Caco-2 cells. Int J Oncol 2005;27: 1449-58.
7. Woo KJ, Kwon TK. Sulforaphane suppresses lipopolysaccharide-induced cyclooxygenase-2 (COX-2) expression through the modulation of multiple targets in COX-2 gene promoter. Int Immunopharmacol 2007;7: 1776-83.
8. Nozoe T, Ezaki T, Kabashima A, Baba H, Maehara Y. Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus. Am J Surg 2005;189:110-5.
9. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995;55:3785-9.
10. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
11. Gasper AV, Al-Janobi A, Smith JA, et al. Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr 2005;82:1283-91.
12. Espramer V, Testini A. Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract. J Pharm Pharmacol 1959;11: 618-23.
13. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007;132: 397-414.
14. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000;95: 2698-709.
15. Gershon MD. Reviewarticle: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004;7:3-14.
16. Tonini M. 5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors. Neurogastroenterol Motil 2005;17: 637-42.
17. Barnes NM, Sharp T. A reviewof central 5-HT receptors and their function. Neuropharmacology 1999; 38:1083-152.
18. Racké K, Reimann A, Schwörer H, Kilbinger H. Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res 1996;73:83-7.
19. Stahl SM. Psychopharmacology of reward and drugs of abuse. In: Essential psychopharmacology neuroscientific basis and practical applications (second edition). Cambridge: Cambridge University Press; 2000. p. 499-538.
20. Jackson MB, Yakel JL. The 5-HT3 receptor channel. Annu Rev Physiol 1995;57:447-68.
21. Fredriksson JM, Lindquist JM, Bronnikov GE, Nedergaard J. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a h-adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2. J Biol Chem 2000;275:13802-11.
22. Brambilla R, Neary JT, Cattabeni F, et al. Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling. J Neurochem 2002; 83:1285-96.
23. Wu WK, Wong HP, Luo SW, et al. 4-(Methylnitrosamino)-1-(3-pyridyl)-1- butanone from cigarette smoke stimulates colon cancer growth via β-adrenoceptors. Cancer Res 2005;65:5272-7.
24. Yang WL, Frucht H. Cholinergic receptor up-regulates COX-2 expression and prostaglandin E(2) production in colon cancer cells. Carcinogenesis 2000; 21:1789-93.
25. Wong HP, Yu L, Lam EK, Tai EK, Wu WK, Cho CH. Nicotine promotes cell proliferation via α7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol Appl Pharmacol 2007;221: 261-7.
26. Traka M, Gasper AV, Smith JA, Hawkey CJ, Bao Y, Mithen RF. Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane. J Nutr 2005;135: 1865-72.
27. Matsunaga T, Shintani S, Hara A. Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab Pharmacokinet 2006;21:1-18.
28. Breyer-Pfaff U, Nill K. Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol. J Pharm Pharmacol 2004;56: 1601-6.
29. Neo JC, Rose P, Ong CN, Chung MC. β-Phenylethyl isothiocyanate mediated apoptosis: a proteomic investigation of early apoptotic protein changes. Proteomics 2005;5:1075-82.
30. Han JM, Lee YJ, Lee SY, et al. Protective effect of sulforaphane against dopaminergic cell death. J Pharmacol Exp Ther 2007;321:249-56.